
About CureDuchenne Ventures
CureDuchenne Ventures is a company based in Newport Beach (United States) founded in 2014. Genetic disorder treatments and care services are supported through ventures.
Company details
CureDuchenne Ventures was established in 2014 in Newport Beach, United States. Focus is placed on the biotechnology sector, where investments are directed toward companies addressing Duchenne muscular dystrophy and related genetic disorders. Operations involve funding research initiatives and providing support for therapeutic developments. Services encompass venture capital for innovative care solutions, with activities centered in the healthcare domain across the United States.
- Headquarters Newport Beach, United States
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website cureduchenne.org/ventures
- Social LinkedIn X Facebook
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CureDuchenne Ventures
CureDuchenne Ventures was founded in 2014.
CureDuchenne Ventures is headquartered in Newport Beach, United States. It is registered at Newport Beach, California, United States.
CureDuchenne Ventures was established in 2014 in Newport Beach, United States. Focus is placed on the biotechnology sector, where investments are directed toward companies addressing Duchenne muscular dystrophy and related genetic disorders. Operations involve funding research initiatives and providing support for therapeutic developments. Services encompass venture capital for innovative care solutions, with activities centered in the healthcare domain across the United States.